Pharmaceuticals

Latest KFF Health News Stories

KHN’s ‘What the Health?’: Picking Up the Pace of Undoing Trump Policies

KFF Health News Original

The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden’s nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

The Shock and Reality of Catching Covid After Being Vaccinated

KFF Health News Original

At least 5,800 people have fallen ill or tested positive for covid two weeks or more after being fully vaccinated, according to the CDC. “I now tell everyone, including my colleagues, not to let their guard down.”

Cuatro respuestas sobre el freno a la vacuna contra covid de Johnson & Johnson

KFF Health News Original

Expertos en salud se preguntan si el freno a la vacuna de J&J a causa de seis casos de mujeres que desarrollaron coágulos luego de recibirla puede impactar negativamente en los esfuerzos de inmunización.

Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You

KFF Health News Original

Over-the-counter covid tests could help speed the economy’s recovery, allowing students and workers to test themselves at home and get quick results. Could they become as ubiquitous as toothpaste and cold remedies on store shelves, or will demand dry up as the nation gets vaccinated?

KHN’s ‘What the Health?’: Planning for Round Two

KFF Health News Original

The ink is barely dry on the recent covid relief bill, but Democrats in Congress and President Joe Biden are wasting no time gearing up for their next big legislative package. Meanwhile, predictions of more states expanding Medicaid have proved premature. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Lauren Weber, who reported the latest KHN-NPR “Bill of the Month” episode.

Scientists Seek Covid Treatment Answers in Cheap, Older Drugs

KFF Health News Original

Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.

How Much of Trump’s Health Agenda Has Biden Undone?

KFF Health News Original

In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.

KHN’s ‘What the Health?’: Getting Down to Work at HHS

KFF Health News Original

After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.

Democrats Eye Medicare Negotiations to Lower Drug Prices

KFF Health News Original

Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.

The Case for Donating US Covid Vaccines Overseas

KFF Health News Original

For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.